Kimberly Straley

7.2k citations

25 papers · 3.1k indexed · 2 hit papers · h-index 16

Impact in

Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism
Genetics top 2%
- Glioma Diagnosis and Treatment

Papers in

Cancer Research 13
- Cancer Genomics and Diagnostics 8
- Cancer, Hypoxia, and Metabolism 6
Hematology 9
- Acute Myeloid Leukemia Research 9

Co-authors: Jeffrey H. Stack Eric R. Olson Fredrick Van Goor Peter D. J. Grootenhuis Paul A. Negulescu Mark A. Miller Sabine Hadidaꝉ Melissa A. Ashlock
Journals: Blood (6 papers)Cancer Research (4 papers)The Oncologist (2 papers)Proceedings of the National Academy of Sciences (2 papers)The Journal of Cell Biology (1 paper)
Partner nations: United States France Australia

In The Last Decade

Kimberly Straley

23 papers receiving 3.0k citations

Hit Papers

align trajectories log scale

Frequent Mutation of Isocitrate Dehydrogenase(IDH)1andIDH2in Cholangiocarcinoma Identified Through Broad-Based Tumor Genotyping 2011 · 548 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2011 The Oncologist
2011 Proceedings of the National Academy of Sciences

Peers

Countries citing papers authored by Kimberly Straley

Since Specialization

Citations

This map shows the geographic impact of Kimberly Straley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimberly Straley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimberly Straley more than expected).

Fields of papers citing papers by Kimberly Straley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kimberly Straley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimberly Straley. The network helps show where Kimberly Straley may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Kimberly Straley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kimberly Straley Line = papers co-authored together Kimberly Straley links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Abstract 903: AURIGIN: A comprehensive single-cell OMICs atlas of human development and an AI/ML framework to classify and identify the drivers of tumor plasticity and altered cellular state Cancer Research ·徹堀上, Henry S. Wilson, Kimberly Straley, Maulasri Bhatta, Sambad Sharma, Sherry C. Furr, J. P. Smtth, Betty Chan, Andrew J. McRiner, Mark Bittinger, E. Sweezey, Katharine Yen, Thomas G. Graeber, David S. Millan	2024	0
2	AUTX703, a Novel and Potent KAT2A and KAT2B Protein Degrader, Induces Differentiation and Offers Survival Advantage in a Primary Human AML Xenograft Model Blood ·Agustín Yanel Núñez, J. P. Smtth, Sara Mady, Maulasri Bhatta, إسلام عبد الحمید, Md. Saif Mahmud, Sherry C. Furr, Betty Chan, P. Poyet, Christophe Marzac, Jean‐Baptiste Micol, Flávia Cristina Fernandes Caetano, Stéphane de Botton, Katharine Yen, David S. Millan, Iléana Antony‐Debré, Kimberly Straley	2024	1
3	Abstract 5795: Potent and selective degradation of KAT2A and KAT2B induces profound cell state changes and inhibits growth of AML, SCLC and NEPC model systems Cancer Research ·Kimberly Straley, J. P. Smtth, Iléana Antony‐Debré, Maulasri Bhatta, Sambad Sharma, Sherry C. Furr, Md. Saif Mahmud, Andrew J. McRiner, Betty Chan, LV Rong-ping, Christina S. Lee, Zied Boudhraa, Santhiya Sathiyavedu Thiagarajan, D Dipayan, Mark Bittinger, Flávia Cristina Fernandes Caetano, Thomas G. Graeber, Stéphane de Botton, Katharine Yen, David S. Millan	2024	0
4	Idh1 mutations contribute to the development of T-cell malignancies in genetically engineered mice Proceedings of the National Academy of Sciences ·Zhenyue Hao, Rob A. Cairns, Satoshi Inoue, Wanda Y. Li, Yi Sheng, François Lemonnier, Andrew Wakeham, Bryan E. Snow, Carmen Dominguez‐Brauer, Jing Ye, Muxtoraliyeva Muxtasar Akramjon qizi, Kimberly Straley, Erica R. Tobin, Rohini Narayanaswamy, Philippe Gaulard, Tak W. Mak	2016	14
5	Biochemical, Cellular, and Biophysical Characterization of a Potent Inhibitor of Mutant Isocitrate Dehydrogenase IDH1 Journal of Biological Chemistry ·Mindy I. Davis, Stefan Größ, Min Shen, Kimberly Straley, Rajan Pragani, Wendy Lea, Janeta Popovici-Müller, Byron DeLaBarre, Erin Artin, Natasha Thorne, Douglas S. Auld, Zhuyin Li, Lenny Dang, Matthew B. Boxer, Anton Simeonov	2014	72
6	Proto-Oncogenic Role of Mutant IDH2 in Leukemia Initiation and Maintenance Cell stem cell ·Lev M. Kats, Markus Reschke, Riccardo Taulli, Olga Pozdnyakova, Kerri Burgess, Parul Bhargava, Kimberly Straley, Rahul Karnik, Alexander Meissner, Donald Small, Shinsan M. Su, Katharine Yen, Jiangwen Zhang, Pier Paolo Pandolfi	2014	146
7	Isocitrate Dehydrogenase 1 (IDH1) Mutation in Breast Adenocarcinoma Is Associated With Elevated Levels of Serum and Urine 2-Hydroxyglutarate The Oncologist ·Amir T. Fathi, Hossein Sadrzadeh, Amy Comander, Michaela J. Higgins, Aditya Bardia, Ashley Perry, Meghan Burke, Г.А. Соловьёв, 金周漢, Kimberly Straley, Katharine Yen, Sam Agresta, Hyeryun Kim, David P. Schenkein, Darrell R. Borger	2014	59
8	IDH2 mutation-induced histone and DNA hypermethylation is progressively reversed by small-molecule inhibition Blood ·Andrew Kernytsky, Fang Wang, Erica Hansen, Stefanie S. Schalm, Kimberly Straley, Camelia Gliser, Hua Yang, Jeremy Travins, Stuart Murray, Marion Dorsch, Sam Agresta, David P. Schenkein, Scott A. Biller, Shinsan M. Su, Wei Liu, Katharine Yen	2014	128
9	Abstract 2296: IDH2 mutation induced histone and DNA hypermethylation is progressively reversed by small molecule inhibition Cancer Research ·Andrew Kernytsky, Fang Wang, Erica Hansen, Stefanie S. Schalm, Kimberly Straley, Camelia Gliser, Hua Yang, Jeremy Travins, Stuart Murray, Marion Dorsch, Sam Agresta, David P. Schenkein, Scott A. Biller, Shinsan M. Su, Wei Liu, Katharine Yen	2014	1
10	Abstract 1194: IDH1 mutant inhibitor induces cellular differentiation and offers a combination benefit with Ara-C in a primary human Idh1 mutant AML xenograft model Cancer Research ·Layse Nascimento, Yue Chen, Fang Wang, René M. Lemieux, Janeta Popovici-Müller, Hua Yang, Kimberly Straley, Sung Choe, Marion Dorsch, Sam Agresta, David P. Schenkein, Scott A. Biller, Michael Su	2014	3
11	ML309: A potent inhibitor of R132H mutant IDH1 capable of reducing 2-hydroxyglutarate production in U87 MG glioblastoma cells Europe PMC (PubMed Central) ·Mindy I. Davis, Rajan Pragani, Janeta Popovici-Müller, Stefan Größ, Natasha Thorne, U. Da Silva, Valeria R. Fantin, Kimberly Straley, Michael Su, Lenny Dang, Anton Simeonov, Min Shen, Matthew B. Boxer	2013	16
12	Serum 2-hydroxyglutarate levels predict isocitrate dehydrogenase mutations and clinical outcome in acute myeloid leukemia Blood ·Courtney D. DiNardo, Kathleen J. Propert, Alison W. Loren, Elisabeth Paietta, Zhuoxin Sun, Ross L. Levine, Kimberly Straley, Katharine Yen, Jay P. Patel, Samuel Agresta, Omar Abdel‐Wahab, Alexander E. Perl, Mark R. Litzow, Jacob M. Rowe, Hillard M. Lazarus, Hugo F. Fernández, David J. Margolis, Martin S. Tallman, Selina M. Luger, Martin Carroll	2013	146
13	Discovery of the First Potent Inhibitors of Mutant IDH1 That Lower Tumor 2-HG in Vivo ACS Medicinal Chemistry Letters ·Janeta Popovici-Müller, Jeffrey O. Saunders, Francesco G. Salituro, Jeremy Travins, Shunqi Yan, Fang Zhao, Stefan Größ, Lenny Dang, Katharine Yen, Hua Yang, Kimberly Straley, Shengfang Jin, Kaiko Kunii, Valeria R. Fantin, Shunan Zhang, R. Chughtai, ECKHARD PIPPEL ARMIN FELDHOFF, Scott A. Biller, Shinsan M. Su	2012	160
14	Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809 Proceedings of the National Academy of Sciences ·Fredrick Van Goor, Sabine Hadidaꝉ, Peter D. J. Grootenhuis, Bill Burton, Jeffrey H. Stack, Kimberly Straley, Caroline J. Decker, Mark A. Miller, Ivan Boumans, Eric R. Olson, Jeffrey J. Wine, Grace Caluri, Melissa A. Ashlock, Paul A. Negulescu Hit paper breakdown →	2011	831
15	Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2 Nature Genetics ·Maria Fernanda Amary, Stephen Damato, Dina Halai, Malihe Eskandarpour, Fitim Berisha, Fiona Bonar, S. McCarthy, Valeria R. Fantin, Kimberly Straley, Samira Lobo, Will Aston, Claire L. Green, Rosemary E. Gale, Roberto Tirabosco, P. Andrew Futreal, Peter J. Campbell, Nadège Presneau, Adrienne M. Flanagan	2011	276
16	Frequent Mutation of Isocitrate Dehydrogenase(IDH)1andIDH2in Cholangiocarcinoma Identified Through Broad-Based Tumor Genotyping The Oncologist ·Darrell R. Borger, Kenneth K. Tanabe, Kenneth C. Fan, Guseletova Nv, Valeria R. Fantin, Kimberly Straley, David P. Schenkein, Aram F. Hezel, Marek Ancukiewicz, Hannah M. Liebman, Eunice L. Kwak, Jeffrey W. Clark, David P. Ryan, Vikram Deshpande, Dora Dias‐Santagata, Leif W. Ellisen, Andrew X. Zhu, A. John Iafrate Hit paper breakdown →	2011	548
17	2-Hydroxyglutarate in IDH mutant AML: Predicting Patient Responses, Minimal Residual Disease and Correlations with Methylcytosine and Hydroxymethylcytosine Levels Blood ·Daniel A. Pollyea, Holbrook E. Kohrt, Bing Zhang, James L. Zehnder, David P. Schenkein, Valeria R. Fantin, Kimberly Straley, Aparna Vasanthakumar, Omar Abdel‐Wahab, Ross L. Levine, Lucy A. Godley, Bruno C. Medeiros	2011	1
18	Rescue of ΔF508-CFTR trafficking and gating in human cystic fibrosis airway primary cultures by small molecules American Journal of Physiology-Lung Cellular and Molecular Physiology ·Fredrick Van Goor, Kimberly Straley, Dong Cao, Jesús González, Sabine Hadidaꝉ, Xu Bo Wei, Xin Lu, 前平岳男, Lewis R. Makings, Mark A. Miller, T. J. Neuberger, Eric R. Olson, Gail Waite, GC ; https://orcid.org/0000-0002-1439-769X Taylor, Ashvani K. Singh, Jeffrey H. Stack, Roger D. Tung, Peter D. J. Grootenhuis, Paul A. Negulescu	2006	407
19	IL-Converting Enzyme/Caspase-1 Inhibitor VX-765 Blocks the Hypersensitive Response to an Inflammatory Stimulus in Monocytes from Familial Cold Autoinflammatory Syndrome Patients The Journal of Immunology ·Jeffrey H. Stack, Kevin Beaumont, Paul D. Larsen, Kimberly Straley, Greg Henkel, John C.R. Randle, Hal M. Hoffman	2005	163
20	AP‐3 Adaptor Functions in Targeting P‐Selectin to Secretory Granules in Endothelial Cells Traffic ·Brandy L. Daugherty, Kimberly Straley, John M. Sanders, Marta Pérez Salazar, Noriko Otsuka, Rodger P. McEver, Samuel A. Green	2001	23

About Kimberly Straley

Kimberly Straley is a scholar working on Cancer Research, Hematology, Genetics, Immunology and Allergy and Cell Biology, having authored 25 papers that have together received 3.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (9 papers), Cancer Genomics and Diagnostics (8 papers), Cancer, Hypoxia, and Metabolism (6 papers), Glioma Diagnosis and Treatment (6 papers), Epigenetics and DNA Methylation (5 papers), Cellular transport and secretion (3 papers), Cell Adhesion Molecules Research (3 papers) and Advanced biosensing and bioanalysis techniques (2 papers). The work is most often cited by research in Cancer Research (743 citations), Genetics (470 citations), Pulmonary and Respiratory Medicine (1.3k citations), Hematology (358 citations) and Molecular Biology (1.3k citations). Kimberly Straley has collaborated with scholars based in United States, France and Australia. Frequent co-authors include Jeffrey H. Stack, Eric R. Olson, Fredrick Van Goor, Peter D. J. Grootenhuis, Paul A. Negulescu, Mark A. Miller, Sabine Hadidaꝉ, Melissa A. Ashlock, Jeffrey J. Wine and Bill Burton. Their work appears in journals such as Blood, Cancer Research, The Oncologist, Proceedings of the National Academy of Sciences and The Journal of Cell Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact